Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Thibault

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Presse Medicale (Paris, France : 1983)|May 3, 2016
[Beware of immunoglobulin's passive transfer when interpreting serological analyses!]Laëtitia Pinte, Julie Vergez, Amélie Liou, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 23, 2020
The contribution of more sensitive hepatitis B surface antigen assays to detecting and monitoring hepatitis B infectionCharlotte Pronier, Daniel Candotti, Laure Boizeau, et al.
Journal of Viral Hepatitis|July 6, 2019
Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategyCharlotte Pronier, Hélène Fontaine, Céline Dorival, et al.
Vaccine|September 11, 2024
Determinants of influenza and COVID vaccine uptake in healthcare workers: A cross-sectional survey during the post-pandemic era in a network of academic hospitals in FranceHervé Gaudouen, Pierre Tattevin, Vincent Thibault, et al.
Emerging Microbes & Infections|November 18, 2020
A lateral flow immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workersRonan Garlantézec, Christopher Heslan, Emilie Tadie, et al.
Antiviral Therapy|July 21, 2004
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovirOlivier Lada, Yves Benhamou, Annie Cahour, et al.
Virology Journal|October 12, 2018
Performance comparison of new Veris and Xpert random access HIV-1 RNA quantification assaysCharlotte Pronier, Sarrah Boukthir, Laura Courtellemont, et al.
Arthritis and Rheumatism|November 1, 2006
Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup studyDavid Saadoun, Mathieu Resche-Rigon, Vincent Thibault, et al.
Studies in Health Technology and Informatics|May 23, 2026
Leveraging Clinical Data Warehouses to Detect Potential False-Negatives EBV Patients AutomaticallyMorgane Pierre-Jean, Pauline Comacle, Denis Delamarre, et al.
AIDS (London, England)|April 20, 2004
Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapyRobert P Myers, Yves Benhamou, Marie Bochet, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Presse Medicale (Paris, France : 1983)|May 3, 2016
[Beware of immunoglobulin's passive transfer when interpreting serological analyses!]Laëtitia Pinte, Julie Vergez, Amélie Liou, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 23, 2020
The contribution of more sensitive hepatitis B surface antigen assays to detecting and monitoring hepatitis B infectionCharlotte Pronier, Daniel Candotti, Laure Boizeau, et al.
Journal of Viral Hepatitis|July 6, 2019
Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategyCharlotte Pronier, Hélène Fontaine, Céline Dorival, et al.
Vaccine|September 11, 2024
Determinants of influenza and COVID vaccine uptake in healthcare workers: A cross-sectional survey during the post-pandemic era in a network of academic hospitals in FranceHervé Gaudouen, Pierre Tattevin, Vincent Thibault, et al.
Emerging Microbes & Infections|November 18, 2020
A lateral flow immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workersRonan Garlantézec, Christopher Heslan, Emilie Tadie, et al.
Antiviral Therapy|July 21, 2004
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovirOlivier Lada, Yves Benhamou, Annie Cahour, et al.
Virology Journal|October 12, 2018
Performance comparison of new Veris and Xpert random access HIV-1 RNA quantification assaysCharlotte Pronier, Sarrah Boukthir, Laura Courtellemont, et al.
Arthritis and Rheumatism|November 1, 2006
Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup studyDavid Saadoun, Mathieu Resche-Rigon, Vincent Thibault, et al.
Studies in Health Technology and Informatics|May 23, 2026
Leveraging Clinical Data Warehouses to Detect Potential False-Negatives EBV Patients AutomaticallyMorgane Pierre-Jean, Pauline Comacle, Denis Delamarre, et al.
AIDS (London, England)|April 20, 2004
Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapyRobert P Myers, Yves Benhamou, Marie Bochet, et al.
Pageof 13